Specialized proresolving lipid mediators in humans with the metabolic syndrome after n–3 fatty acids and aspirin
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Specialized proresolving lipid mediators in humans with the metabolic syndrome after n–3 fatty acids and aspirin
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF CLINICAL NUTRITION
Volume 102, Issue 6, Pages 1357-1364
Publisher
Oxford University Press (OUP)
Online
2015-11-12
DOI
10.3945/ajcn.115.116384
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue
- (2014) Romain A. Colas et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Short-term n-3 fatty acid supplementation but not aspirin increases plasma proresolving mediators of inflammation
- (2014) Anne Barden et al. JOURNAL OF LIPID RESEARCH
- Maresin Biosynthesis and Identification of Maresin 2, a New Anti-Inflammatory and Pro-Resolving Mediator from Human Macrophages
- (2014) Bin Deng et al. PLoS One
- Diversity of lipid mediators in human adipose tissue depots
- (2013) Joan Clària et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Resolvins, Specialized Proresolving Lipid Mediators, and Their Potential Roles in Metabolic Diseases
- (2013) Matthew Spite et al. Cell Metabolism
- Impaired Local Production of Proresolving Lipid Mediators in Obesity and 17-HDHA as a Potential Treatment for Obesity-Associated Inflammation
- (2013) A. Neuhofer et al. DIABETES
- The effect of EPA and DHA on metabolic syndrome patients: a systematic review of randomised controlled trials
- (2012) Eduardo Lopez-Huertas BRITISH JOURNAL OF NUTRITION
- Resolvins D1, D2, and Other Mediators of Self-Limited Resolution of Inflammation in Human Blood following n-3 Fatty Acid Supplementation
- (2012) E. Mas et al. CLINICAL CHEMISTRY
- Omega-6 docosapentaenoic acid-derived resolvins and 17-hydroxydocosahexaenoic acid modulate macrophage function and alleviate experimental colitis
- (2012) Cheng-Ying Chiu et al. INFLAMMATION RESEARCH
- Identification and Structure Determination of Novel Anti-inflammatory Mediator Resolvin E3, 17,18-Dihydroxyeicosapentaenoic Acid
- (2012) Yosuke Isobe et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Specialized Proresolving Mediators Enhance Human B Cell Differentiation to Antibody-Secreting Cells
- (2012) S. Ramon et al. JOURNAL OF IMMUNOLOGY
- Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation
- (2012) D. El Kebir et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Resolvins and Protectins in Inflammation Resolution
- (2011) Charles N. Serhan et al. CHEMICAL REVIEWS
- Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation
- (2011) Sungwhan F. Oh et al. JOURNAL OF CLINICAL INVESTIGATION
- Novel Lipid Mediators Promote Resolution of Acute Inflammation
- (2010) Matthew Spite et al. CIRCULATION RESEARCH
- Obesity-induced insulin resistance and hepatic steatosis are alleviated by ω-3 fatty acids: a role for resolvins and protectins
- (2009) Ana González-Périz et al. FASEB JOURNAL
- Resolvin E1 Receptor Activation Signals Phosphorylation and Phagocytosis
- (2009) Taisuke Ohira et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions
- (2008) Charles N. Serhan et al. JOURNAL OF EXPERIMENTAL MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started